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Abstract A rapid, ultra high-performance liquid chromato-
graphic (UHPLC) method has been developed and validated
for simultaneous identification and analysis of the isoflavones
genistein, daidzein, glycitin, puerarin, and biochanin A, and
the flavonoids (±)-catechin, (−)-epicatechin, rutin, hesperidin,
neohesperidin, quercitrin, and hesperetin in human urine.
Urine samples were incubated with β-glucuronidase/
sulfatase. UHPLC was performed with a Hypersil Gold
(50×2.1 mm, 1.9 μm) analytical column. Elution was
with a gradient prepared from aqueous trifluoroacetic
acid (0.05%) and acetonitrile. UV detection was per-
formed at 254 and 280 nm. The calibration curves were
indicative of good linearity (r
2≥0.9992) in the range of
interest for each analyte. LODs ranged between 15.4 and
107.0 ngmL
−1 a n d3 . 9a n d2 0 . 4n g m L
−1 for flavonoids
and isoflavones, respectively. Intra-day and inter-day
precision (C.V., %) was less than 3.9% and 3.8%,
respectively, and accuracy was between 0.03% and 5.0%.
Recovery was 70.35–96.58%. The method is very rapid,
simple, and reliable, and suitable for pharmacokinetic
analysis. It can be routinely used for simultaneous
determination of these five isoflavones and seven flavonoids
i nh u m a nu r i n e .T h em e t h o dc a na l s ob ea p p l i e dt o
studies after administration of pharmaceutical preparations
containing isoflavones and flavonoids to humans.
Keywords Isoflavones.Flavonoids.UHPLC.
Pharmacokinetics
Introduction
In recent years, much attention has been devoted to natural
substances, for example isoflavones and flavonoids, with
antioxidant activity. These natural antioxidants are mainly
found in vegetables, fruit, and wheat [1]. Interest in these
compounds is because of the increasing incidences of
serious pathologies, for example cancer, cardiovascular
diseases, or inflammation, caused, in part, by the harmful
effects of free radicals. There is strong epidemiological
evidence that diet has a protective effect against a number
of these complex diseases; thus, there is an increased
interest in natural antioxidant compounds [2–4].
Therefore, a daily diet that includes foods and food
products containing antioxidants is important to health and
nutrition. Isoflavones and flavonoids are biologically active
phytochemicals that humans are exposed to mainly through
food intake. Flavonoids are found in nearly every plant.
However, isoflavones are usually treated separately from
othersubclassesofantioxidantsbecausethesephytochemicals
are found in significant concentrations chiefly in soybeans
and soy-related foods. Interest in supplementing the diet with
isoflavones and flavonoids is constantly increasing. These
compounds are available as various pharmaceutical prepara-
tions that are currently being recommended by doctors.
In order to probe the potential benefits, or adverse
effects, of isoflavone and flavonoid consumption more
efficiently, it is necessary to develop analytical methods
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of analytes in low volumes of human fluids. These methods
should also be capable of high-throughput sample analysis.
Different methods have been reported in the literature for
analysis of individual flavonoids or isoflavones; however,
there is no literature that describes the simultaneous
determination of isoflavones and flavonoids by ultra high-
performance liquid chromatography (UHPLC).
HPLC, with various types of detectors, for example
ultra-violet (UV) [5–9], diode array [10], coulometric array
[11], and mass spectrometry [12–14]), is the most common
method used for determination of flavonoids in biological
fluids. Flavonoids have been quantified in the presence of
other antioxidants using electrochemical detection by
Bolarinwa and Linseisen [15]. Papers have been published
on flavonoid separation using different mobile phases; most
separations have been accomplished on C8 or C18 reversed-
phase columns.
Measurements of isoflavones in biological samples have
been conducted using gas chromatography–mass spectrom-
etry (GC–MS) [16, 17] or HPLC, usually with UV [18–20],
electrochemical [21, 22], or mass spectrometric [23–26]
detection. Methods such as liquid–liquid extraction (LLE)
or solid-phase extraction (SPE) have been used for
isoflavone extraction and purification, because biological
samples require clean up [27, 28].
Recently,commerciallyavailableUHPLChasprovedtobe
one of the most promising developments in fast chromato-
graphic separations. There has been substantial focus on
UHPLC separations with the objective of reducing analysis
times while maintaining good efficiency. In this work, a new
gradient reversed-phase UHPLC method was developed for
simultaneous analysis of the isoflavones genistein (GT),
daidzein (DA), glycitin (GLY), puerarin (PUR), and biocha-
nin A (BIO) and the flavonoids (±)-catechin ((±)-CA),
(−)-epicatechin ((−)-EC), rutin (RUT), hesperidin (HSD),
neohesperidin (NHSD), quercitrin (QUR), and hesperetin
(HST). The development of new and highly effective techni-
ques for isolation, separation, identification, and determination
of isoflavones and flavonoids is very important because these
substances are known to have very positive physiological
effects on human health. As far as we are aware, there is no
literature related to the simultaneous analysis of isoflavones
and flavonoids in biological samples. This newly developed
method is applicable for the analysis of human urine.
Experimental
Reagents and chemicals
The flavonoids (±)-CA, (−)-EC, RUT, HSD, NHSD, QUR,
and HST, the isoflavones GT, DA, GLY, PUR, and BIO,
and β-glucuronidase/sulfatase (crude solution from Helix
pomatia, type HP-2, G7017) were purchased from Sigma
Chemicals (St Louis, MO, USA) and Aldrich Chemicals
(Milwaukee, WI, USA). HPLC-grade acetonitrile, water,
trifluoroacetic acid, formic acid, sodium acetate buffer
(pH 4.66), and phosphate buffer (pH 2.4) were obtained
from Merck (Darmstadt, Germany). Analytical-grade
methanol, acetonitrile, and acetone were purchased from
POCh (Gliwice, Poland).
Standard stock solutions (1 mgmL
−1) of the flavonoids
and isoflavones were prepared in methanol as solvent.
Combined standard solutions containing the flavonoids and
isoflavones were prepared just before use by mixing
individual stock solutions and diluting these mixtures with
methanol. All solutions were stored at 4 °C. In this study an
internal standard was not used.
Human urine was obtained from healthy volunteers who
were on a diet rich in flavonoids and orally-administrated
tablets of flavonoids and isoflavones. Human urine samples
taken from patients treated with β-blockers were obtained
from the Medical University in Katowice (Poland). The
subjects were ten healthy volunteers aged 21–48 years.
Urine samples were collected just before administration
of pharmaceutical preparations containing isoflavones
and flavonoids and 0–2, 2–4, 4–6, 6–8, 8–10, 10–12,
and 12–24 h after administration. Human urine was
stored at −18 °C.
Chromatographic conditions
The UHPLC system (Merck Hitachi, Germany) was
equipped with a model L-2160U pump, a model L-2400U
absorbance detector, a model L-2200U autosampler, a
model L-2350U thermostatted column compartment, and a
degasser module.
The flavonoids and isoflavones were separated on a
Hypersil Gold (50×2.1 mm, 1.9 μm) reversed-phase
column (Thermo Scientific) by gradient elution using
0.05% trifluoroacetic acid (TFA) in water (solvent A)
and acetonitrile (solvent B). The gradient profile was:
0–0.5 min, from 5% to 20% solvent B (flow rate from
1 . 0t o0 . 5m L m i n
−1); 2.0 min, 40% solvent B (flow rate
0.4 mLmin
−1); 3.5 min 90% solvent B (flow rate 0.9 mL
min
−1). The detector wavelengths were set at 254 and
280 nm. The injection volume was 2 μL. The temperature
of the column oven was set to 25 °C.
Isoflavone and flavonoid identification was performed
according to retention time by comparison with reference
standards. Furthermore, the presence of the individual
flavonoids and isoflavones in the urine matrix was
confirmed by adding a mixed standard solution to the urine
samples. Data acquisition and integration were performed
using EZ Chrom Elite System Manager.
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Urine samples were collected from healthy volunteers after
oral administration of tablets containing flavonoids and
isoflavones for a period of 1 h. For sample preparation,
2.5 mL urine was mixed with 0.5 mL acetonitrile and
0.5 mL methanol. After shaking for 1 min, the sample
was transferred to a centrifuge tube and centrifuged using
a refrigerated Universal Centrifuge Z 323 K (Hermle
Labortechnik, Germany) at 4724×g for 15 min at room
temperature (ca. 22 °C). The clear supernatant was
incubated with 100 μL1m o l L
−1 sodium acetate buffer
(pH 4.66) and 40 μL β-glucuronidase/sulfatase (crude
preparation from H. pomatia)f o r1 8ha t3 7° C .T h e
hydrolyzed urine sample was diluted with 1 mL phosphate
buffer (0.1 molL
−1,p H2 . 4 )[ 7].
Extraction was performed with the Bakerbond SPE-12G
system (J.T. Baker, Deventer, Netherlands). The hydrolyzed
sample was applied to Oasis HLB extraction cartridges
(6 mL, 500 mg, Waters), preconditioned successively with
6 mL methanol and 6 mL 0.1% formic acid, and allowed to
run through. Isoflavones and flavonoids were eluted with
5 mL methanol–acetone–formic acid 4.5:4.5:1 (v/v) and the
eluate was evaporated to dryness. Finally, the residue was
redissolved in 1 mL 0.05% trifluoroacetic acid (TFA) in
water and filtered through a 0.45-μm membrane filter.
Samples (2 μL) were injected on to the chromatographic
column using the system autosampler. The analysis was
repeated six times.
Pharmacokinetic analysis
Pharmacokinetic analysis was carried out using PK Solutions
2.0 pharmacokinetic analysis computer software. The area
under the curve (AUC), maximum plasma concentration
(Cmax), and time needed to reach the maximum plasma
concentration (Tmax) were determined by the software.
The elimination rate constant (Kel) was obtained from the
terminal slope by use of regression analysis. The half-life
(t1/2) of the drug was calculated by use of the relationship
t1/2=0.693/Kel.
Method validation
The newly developed UHPLC method was validated for
linearity, limit of detection (LOD), limit of quantification
(LOQ), precision, accuracy, selectivity, and recovery.
Calibration standards were prepared by adding appro-
priate amounts of the stock solutions to flavonoid and
isoflavone-free human urine and then performing serial
dilutions with additional blank urine sample to obtain
different concentrations. Six replicate aliquots of these
solutions were injected on to the UHPLC system and the
analyses were carried out as described in the section
“Chromatographic conditions”. Calibration curves were
constructed by plotting peak area against concentration for
each analyte and the regression equation was calculated for
each curve. The data obtained were submitted to regression
analysis and correlation coefficients were calculated for
each flavonoid and isoflavone using Excel.
The LOD and LOQ were calculated using Eqs. 1 and 2,
respectively [29]. The calculated theoretical detection and
quantification limits were confirmed by analysis of these
concentrations using the developed method.
LOD ¼ S:D:   3:3 ðÞ =slope of calibration curve ð1Þ
LOQ ¼ S:D:   10 ðÞ =slope of calibration curve ð2Þ
where S.D. is the standard deviation of the intercept.
The precision and accuracy of the UHPLC method were
evaluated by analysing blank samples of urine spiked with
high, medium, and low concentrations of the flavonoids
and isoflavones. The intra-day variance was determined by
assaying six replicates on the same day and inter-day
variance was assessed over five consecutive days. Precision
was expressed as relative standard deviation (C.V., %).
Accuracy was determined by comparing the calculated
concentrations from the calibration curves with the known
concentrations.
Control human urine obtained from six volunteers, was
assessed using the procedure described above and com-
pared with results from respective urine samples to evaluate
the selectivity of the method. The resulting chromatograms
were examined to determine the presence of any peak that
could interfere with the analysis of flavonoids and
isoflavones.
Absolute recovery was calculated by injecting urine
spiked with the known amounts of each examined
compound. The recoveries were tested at low, medium,
and high concentrations. The spiked urine samples were
extracted using the described SPE method and analysed
with the proposed UHPLC method. Furthermore, the
concentrations of flavonoids were calculated using the
calibration curves. The recoverywas calculatedbycomparing
the determined amounts for the extracted urine samples with
the known amounts added.
Results and discussion
Optimization of the UHPLC method
In this study a UHPLC method with UV detection is
reported for quantification of flavonoids and isoflavones in
human urine. Analyses were performed at 254 nm (RUT,
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HSD, NHSD, HST), which are the wavelengths
corresponding to the absorption maximum for most of the
flavonoids and isoflavones.
Various columns were tested to separate the flavonoids
and isoflavones. It was determined that these compounds
can be separated by using a Hypersil Gold (50×2.1 mm,
1.9 μm) column. However, peak tailing and peak broadening
of the flavonoids and isoflavones occurred with this column.
The separation is complicated by the fact that biological
samplesconsistofmanycompoundswithdifferentproperties.
Some sample components are highly polar whereas
others are non-polar. Different organic solvent mixtures
(e.g., methanol–water or acetonitrile–water mixtures)
were tried but the separation remained unsatisfactory.
With a methanol–water mobile phase, the elution time of
the flavonoids and isoflavones was prolonged and their
separation was improved.
In this research, we studied the effects of different
organic acids in the mobile phase (solvent A: trifluoroacetic
(TFA), acetic, or formic acid; solvent B: acetonitrile) on
the separation of the flavonoids and isoflavones. Basic
chromatographic performance data, for example resolu-
tion (RS), selectivity (α), peak asymmetry, and peak area,
were selected to evaluate the UHPLC method. The
resolution and peak asymmetries of the flavonoids and
isoflavones using different organic acids in the mobile
p h a s ea r es h o w ni nF i g .1a. Using acetic acid and formic
acid, we observed a large increase in peak asymmetry and
large decrease in peak height for the flavonoids and
isoflavones. The effect of the organic acid on the
separation is directly dependent on the particular flavo-
noids and isoflavone. The best peak width (0.07 min), RS
(3.62), and α (1.08) for the separated compounds was
observed with TFA. On the basis of the average values of
the chromatographic performance data, the most effective
mobile phase combination was TFA (solvent A) and
acetonitrile (solvent B).
The pH of the mobile phase markedly influences the
chromatographic separation of many compounds; thus, we
studied this effect on the separation of flavonoids and
isoflavones by adjusting the pH of the TFA mobile phase.
The tested pH values were 2.5, 3.5, 4.5, 5.5, and 6.0. The
best peak height, peak asymmetry, and resolution values for
flavonoid and isoflavone detection and separation were
obtained by using the lowest pH mobile phase (Fig. 1b).
Fig. 1 Effect on the resolution (mean RS) and peak asymmetry (mean
asymmetry) of the analytes of different composition of solvent A in
the mobile phase (a), pH (b), and temperature (c)
Fig. 2 Chromatogram obtained from a mixed standard containing
flavonoids (10 μgmL
−1 (±)-CA, 10 μgmL
−1 (−)-EC, 5 μgmL
−1 RUT,
5 μgmL
−1 QUR, 5 μgmL
−1 HSD, 5 μgmL
−1 NHSD, 5 μgmL
−1 HST)
and isoflavones (3 μgmL
−1 PUR, 7 μgmL
−1 GLY, 3 μgmL
−1 DA,
3 μgmL
−1 GT, 3 μgmL
−1 BIO) by use of the UHPLC method
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effects on the separation. Using TFA at pH 6.0 increased
the peak width (9.5%), peak asymmetry (9.6%), and
retention time. More importantly, it reduced the selectivity
and resolution. In addition, we observed a large
decrease in the flavonoid and isoflavone peak heights
at pH 6.0. Therefore, the chromatographic conditions
were further studied using 0.05% TFA, pH 2.5, as
mobile phase A.
The effect of increasing the column temperature from
20 °C to 40 °C was evaluated using the Hypersil Gold
column at the optimum chromatographic conditions. Tem-
peratures higher than 35 °C had a negative effect on the
separation and on peak symmetry (Fig. 1c). The higher
temperature increased the average peak width (32.9%) and
peak asymmetry (11.9%), and reduced the selectivity
(1.7%) and resolution (10.9%). Increasing the temperature
to 40 °C reduced the retention times that, in turn, further
reduced the separation of the unresolved compounds. The
signals for PUR and (−)-EC were still not well resolved.
The peak heights of the flavonoids and isoflavones
increased with increasing temperature, but the peak
symmetry and efficiency decreased. We prefer better
chromatographic separation (i.e., no co-eluting peaks) to
improved peak height (sensitivity); thus we decided to
operate at 25 °C.
The optimized chromatographic conditions for the
separation of the flavonoids and isoflavones were: solvent
A, 0.05% TFA in water (pH 2.5); solvent B, acetonitrile;
columntemperature,25°C.Thegradientelutionandflowrate
conditions are described in the section “Chromatographic
conditions”. With these conditions, the best peak shape and
separation were achieved. It was shown that separation of the
flavonoids and isoflavones could be achieved within
3.5 min. Chromatograms demonstrating the separation are
presented in Fig. 2.
Method validation
The LOD and LOQ of all the compounds analysed are
listed in Table 1. A six-point linearity curve was
constructed for each analyte. Samples were quantified
using the concentration–peak-area relationships and were
calculated by use of regression analysis y ¼ ax þ b ðÞ .T h e
minimum correlation coefficient of the analyte calibration
curves was greater than 0.9992; the regression data are
listed in Table 1.
Both intra-day and inter-day precision, as relative
standard deviation (C.V., %), were lower than 3.90%. The
accuracy of the method was investigated by measurement
of recovery. The results obtained showed the method was
accurate. The percentage bias for all calibration samples
varied from 0.03% to 5.00%. The accuracy results are listed
in Table 2.
Selectivity experiments were carried out using human
urine samples that did not contain the target compounds. A
chromatogram obtained by UHPLC from a blank sample of
urine is shown in Fig. 3. There were no interfering peaks at
retention times corresponding to the analysed flavonoids
and isoflavones. There are some additional unidentified
Table 1 Calibration data for all the compounds examined (n=6)
Compound Linear dynamic range
a
(μgmL
−1)
Slope (a) Sa Intercept (b) Sb Sxy Correlation
coefficient, r
2
LOD
(ngmL
−1)
LOQ
(ngmL
−1)
Flavonoids
(±)-CA 0.5–10 10290 139 −744 804 1194 0.9993 103.2 309.6
(−)-EC 0.5–10 11543 162 422 936 1389 0.9992 107.0 321.1
RUT 0.05–5 33445 290 −700 703 1289 0.9997 15.4 46.2
QUR 0.05–5 34721 337 − 1256 817 1497 0.9996 15.5 46.6
HSD 0.1–10 18112 230 3789 1230 2192 0.9992 32.0 96.1
NHSD 0.1–10 23060 247 1898 1319 2351 0.9994 31.5 94.4
HST 0.1–10 25611 280 2429 1494 2664 0.9994 32.1 96.3
Isoflavones
PUR 0.04–3 68987 725 564 543 991 0.9996 10.4 31.2
GLY 0.02–1.5 74582 295 255 221 404 0.9999 3.9 11.7
DA 0.04–3 91377 1019 603 763 1393 0.9995 11.0 33.1
GT 0.07–3 65955 818 −1549 1226 2212 0.9994 20.4 61.3
BIO 0.04–3 109929 784 1700 1041 2097 0.9997 12.5 37.5
aLinear regression analysis with the regression equation: y ¼ ax þ b, in which x is the concentration inμgmL
−1 and y is the peak area. Sa is the standard
deviation of the slope, Sb the standard deviation of the intercept, and Sxy the residual standard deviation of the regression coefficient
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but these peaks do not interfere with the flavonoids and
isoflavones of interest.
The percentage recoveries for all analysed compounds
from spiked human urine were evaluated at low (0.40–
0.80 μgmL
−1), medium (0.75–2.00 μgmL
−1) and high
(1.20–8.00 μgmL
−1) concentrations. A high absolute
percentage recovery indicates that the method can be
successfully used for the determination of the analysed
flavonoids and isoflavones in human urine samples. The
Table 2 Intra-day and inter-day precision, accuracy, and absolute recovery of flavonoids and isoflavones from human urine (n=6)
Compound Added (μgmL
−1) Intra-day Inter-day
Measured
(μgmL
−1)
C.V.
a (%) Accuracy
(%)
Absolute
recovery (%)
Measured
(μgmL
−1)
C.V.
a (%) Accuracy
(%)
Recovery
(%)
Flavonoids
(±)-CA 0.80 0.66 0.78 0.83 81.85 0.66 0.64 0.57 82.34
2.50 2.06 1.71 −1.11 82.43 2.04 1.51 −1.02 81.61
8.00 6.73 1.80 −2.74 84.12 6.58 1.38 −2.16 82.27
(−)-EC 0.80 0.72 1.05 0.15 90.37 0.72 1.04 −0.57 89.83
2.50 2.13 1.95 0.46 85.37 2.07 2.60 −3.01 82.81
8.00 7.27 0.34 −0.15 90.94 7.15 0.85 −1.70 89.39
RUT 0.80 0.56 0.30 −1.07 70.35 0.56 1.94 −0.54 70.00
2.50 1.69 0.47 −4.70 71.00 1.69 0.63 −4.57 67.73
4.00 2.84 0.62 −3.21 70.95 2.87 0.63 1.04 71.66
QUR 0.80 0.62 1.88 −1.29 77.89 0.62 1.91 −0.12 77.81
2.50 2.04 2.25 −2.08 81.56 2.06 2.21 0.97 82.29
8.00 6.45 0.39 2.99 80.62 6.49 1.40 0.72 81.18
HSD 0.80 0.60 0.82 −1.73 75.41 0.59 2.54 −2.23 73.75
2.50 1.92 0.49 −1.22 76.98 1.89 0.59 −1.59 75.75
8.00 5.87 1.59 −0.54 73.35 5.77 1.26 −1.67 72.10
NHSD 0.80 0.64 2.99 −2.09 80.09 0.63 2.09 −0.96 79.29
2.50 2.10 0.98 −0.12 84.11 2.09 0.98 −0.69 83.52
8.00 6.60 2.27 −1.07 82.48 6.58 2.40 −0.17 82.31
HST 0.80 0.61 1.81 0.05 75.89 0.60 2.20 −0.34 75.66
2.50 1.99 0.34 0.03 79.56 1.96 0.96 −1.63 78.29
8.00 6.40 0.39 0.39 80.06 6.27 1.35 −2.06 78.38
Isoflavones
PUR 0.24 0.21 3.16 −0.90 86.19 0.20 3.15 −3.92 82.83
0.75 0.62 1.96 −4.27 82.58 0.61 2.34 −1.55 81.26
1.20 1.02 3.82 −2.47 85.27 1.01 2.77 −0.55 84.76
GLY 0.24 0.23 2.00 −1.27 95.18 0.22 2.89 −3.97 91.37
0.75 0.61 1.80 −0.33 81.10 0.58 2.84 −4.94 77.13
1.20 0.97 3.62 −0.64 81.07 0.93 3.68 −4.67 77.26
DA 0.24 0.23 3.41 −2.22 96.09 0.23 3.79 1.55 96.57
0.75 0.67 0.77 −0.04 89.21 0.67 0.56 −0.44 88.85
1.20 1.00 0.34 1.13 83.22 1.02 0.45 1.82 84.72
GT 0.48 0.41 1.17 −4.99 85.10 0.40 1.80 −2.34 83.14
1.50 1.10 0.23 −4.09 73.40 1.04 0.56 −5.00 69.73
2.40 1.75 2.94 −3.20 73.11 1.69 2.58 −3.83 70.33
BIO 0.24 0.22 2.10 −0.70 90.83 0.21 1.70 −2.26 88.74
0.75 0.72 1.12 −4.90 96.58 0.70 1.31 −2.93 93.78
2.40 2.12 2.09 −4.53 88.54 2.03 1.62 −4.37 84.64
aCoefficient of variation of the concentrations measured
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isoflavones are shown in Table 2.
Analysis of flavonoids and isoflavones in human urine
As a typical application of the developed gradient reversed-
phase UHPLC method, urinary excretion of flavonoids and
isoflavones from healthy volunteers was investigated. To
further evaluate the applicability of the method, a subset of
urine samples from an intervention study that involved
patients on a diet high in flavonoid content, and with
supplementation of isoflavones was analysed. The pharma-
ceutical preparations that were taken by the volunteers,
contained GT, DA, GLY, and RUT.
Enzymatic hydrolysis was used for preparation of human
urine samples containing isoflavones and flavonoids. In this
work, the glycosides were hydrolyzed with pure β-
glucuronidase and sulfatase (crude preparation from H.
pomatia) in acetate buffer (pH 4.66), in order to release the
aglycones [7]. The concentrations of analysed compounds
increased after hydrolysis, because of conversion of the
glycosides to the aglycone forms. Flavonoids and isofla-
vones are analysed as aglycones because of the high cost of
the reference compounds or because some of them are not
commercially available.
Flavonoid and isoflavone peak identification was
achieved by comparison of retention times and by use of
the standard addition method. UV detection was chosen for
quantitative analysis because the detector was sufficiently
sensitive and accurate for the prominent flavonoids and
isoflavones in urine samples. The flavonoid and isoflavone
content of the urine samples was determined using
calibration curves.
Analysis of the 24-h urinary excretion of GLY, DA, and
GT demonstrated that the cumulative amounts gradually
increased during the collection period after oral adminis-
tration of these isoflavones to the subject. The mean urine
concentration–time profiles of GLY, DA, and RUT are
shown in Fig. 4. The flavonoid and isoflavone concen-
trations reached a maximum between 5 and 8 h after dosing
with a level of 5482.33±10.78 ngmL
−1 for GLY, 228.03±
5.34 ngmL
−1 for DA, and 780.18±10.39 ngmL
−1 for RUT.
Assuming the mean 24-h urine volume is 1.4 L [17], the
approximate average daily output is 1.73 mg, 0.14 mg, and
0.19 mg of GLY, DA and RUT, respectively. The
percentage of GLY, DA, and RUT excreted in urine within
24 h after ingestion of the tablets was 30%, 17%, and 1%,
respectively, of the administered dose. The corresponding
pharmacokinetic data for GLY, DA, and RUT are presented
in Table 3.
The urine samples were also tested for (±)-CA, (−)-EC,
QUR, and HST, which are components of a diet rich in
fruits, vegetables, tea, and wine. The mean concentrations
of these flavonoids were: 5427.34 ngmL
−1 for (±)-CA,
2724.26 ngmL
−1 for (−)-EC, and 73.57 ngmL
−1 for QUR.
Fig. 4 Mean urine concentration–time profiles (±S.D) of (a)G L Y ,( b)D A ,a n d( c) RUT in healthy volunteers after oral administration of
pharmaceutical preparations
Fig. 3 Chromatogram obtained from a blank urine sample by use of
the UHPLC method
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relationship between the concentrations of these com-
pounds and the collection times of the urine samples is
not shown.
An example chromatogram obtained from a urine sample
is presented in Fig. 5. Based on the results, the sensitivity is
sufficient to determine the presence of flavonoids and
isoflavones in urine without complicated pre-treatment of
the samples. Dilution studies revealed that urine samples
with analyte concentrations outside the linear range of the
calibration curves could be successfully analysed after
dilution of the urine sample with organic solvents.
HPLC–ESI-MS–MS was used for confirm the presence
of the compounds because of its high selectivity in the
detection of flavonoids and isoflavones in complex biological
matrices.
Conclusion
In the work discussed in this paper, a simple gradient
reversed-phase UHPLC method was developed and vali-
dated for simultaneous identification and determination of
flavonoids and isoflavones in human urine. The UHPLC
method was developed for quantification of the flavonoids
(±)-catechin, (−)-epicatechin, rutin, hesperidin, neohesper-
idin, quercitrin, and hesperetin and the isoflavones genis-
tein, daidzein, glycitin, puerarin, and biochanin A. This
method enables rapid, accurate, and extensive analysis of
flavonoids and isoflavones, utilizing a simple but effective
sample-preparation procedure; thus, it enables large-scale
epidemiological studies to be conducted. Hydrolysis of
urine samples with enzyme resulted in high recoveries of
flavonoids and isoflavones. The developed method can be
applied to monitoring the concentration of isoflavones and
flavonoids in humans without requiring hospitalization,
because determination of these compounds in urine does
not require invasive sample collection.
Finally, this new UHPLC method also has potential
applicability to bioequivalence studies of flavonoids and
isoflavones and will be useful for tracing the therapeutic
effects of medications for certain diseases.
Fig. 5 Chromatogram obtained by use of the UHPLC method from a
urine sample containing flavonoids (6.38 μgmL
−1 (±)-CA, 5.24 μg
mL
−1 (−)-EC, 0.79 μgmL
−1 RUT, 0.15 μgmL
−1 QUR, HST (nq)) and
isoflavones (5.48 μgmL
−1 GLY, 0.19 μgmL
−1 DA). The sample was
obtained from a healthy volunteer on a diet rich in flavonoids and
orally administered tablets containing the flavonoids and isoflavones
(collected 5 h after administration of the tablets)
Table 3 Pharmacokinetic data for GLY, DA, and RUT after the oral administration of pharmaceutical preparations (n=6)
Data GLY (mean±S.D.)
f DA (mean±S.D.)
f RUT (mean±S.D.)
f
AUC(0–t)
a (μghmL
−1) 86628.8±1769.0 7714.0±410.4 12808.7±77.3
AUC(0–∞)
a (μghmL
−1) 86678.1±1766.7 7728.9±414.1 12815.4±78.9
Cmax
b (ngmL
−1) 5482.3±10.8 228.0±5.34 780.2±10.39
Tmax
c (h) 5 7 8
t1/2
d (h) 3.31±0.08 4.43±0.86 3.98±0.53
Kel
e 0.21±0.01 0.16±0.06 0.17±0.02
aArea under the urine concentration–time curve
bPeak concentration
cTime to reach peak concentration
dTerminal half-life
eElimination rate constant
fValues are mean±S.D
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